Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Hydrogel-based Drug Delivery Device Market Outlook, In‑Depth Analysis & Forecast to 2032
Global Hydrogel-based Drug Delivery Device Market Outlook, In‑Depth Analysis & Forecast to 2032
Industry: Medical Devices & Consumables
Published Date: 2026-03-26
Pages: 198 Pages
Report ld: 6340242
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Hydrogel-based Drug Delivery Device market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
From a downstream perspective, Hospital accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).
Hydrogel-based Drug Delivery Device leading manufacturers (including AstraZeneca Plc., Columbia Laboratories Inc., Mylan, Teva Pharmaceuticals USA Inc., Blairex Laboratories Inc., ARx LLC., Endo International plc, BioDelivery Sciences International Inc., Indivior PLC, GSK Plc, etc.), dominate supply; the top five capture approximately % of global revenue, with AstraZeneca Plc. leading 2025 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Hydrogel-based Drug Delivery Device market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- AstraZeneca Plc.
- Columbia Laboratories Inc.
- Mylan
- Teva Pharmaceuticals USA Inc.
- Blairex Laboratories Inc.
- ARx LLC.
- Endo International plc
- BioDelivery Sciences International Inc.
- Indivior PLC
- GSK Plc
- Pfizer Inc.
- Aquestive Therapeutics Inc.
- ZIM LABORATORIES LIMITED
- IntelGenx Corp.
- NEXGEL
- Bliss GVS Pharma Ltd.
- Teika Pharmaceutical Co. Ltd.
- Medherant Limited
- Galderma
- Johnson & Johnson
- Bausch and Lomb
- Ferring B.V
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Oral
- Buccal
- Rectal
- Vaginal
- Other
Segment by Application
- Hospital
- Clinic
- Other
CHAPTER OUTLINE
Chapter 1: Defines the Hydrogel-based Drug Delivery Device study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Hydrogel-based Drug Delivery Device: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Hydrogel-based Drug Delivery Device Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Oral
1.2.3 Buccal
1.2.4 Rectal
1.2.5 Vaginal
1.2.6 Other
1.3 Market Segmentation by Application
1.3.1 Global Hydrogel-based Drug Delivery Device Market Size by Application, 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Hydrogel-based Drug Delivery Device Revenue Estimates and Forecasts (2021-2032)
2.2 Global Hydrogel-based Drug Delivery Device Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Hydrogel-based Drug Delivery Device Sales Estimates and Forecasts (2021-2032)
2.4 Global Hydrogel-based Drug Delivery Device Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)
3 Competitive Landscape
3.1 Global Hydrogel-based Drug Delivery Device Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Hydrogel-based Drug Delivery Device Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Oral: Market Share by Key Manufacturers
3.5.2 Buccal: Market Share by Key Manufacturers
3.5.3 Rectal: Market Share by Key Manufacturers
3.5.4 Vaginal: Market Share by Key Manufacturers
3.5.5 Other: Market Share by Key Manufacturers
3.6 Global Hydrogel-based Drug Delivery Device Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Product Segmentation
4.1 Global Hydrogel-based Drug Delivery Device Sales Performance by Type
4.1.1 Global Hydrogel-based Drug Delivery Device Sales Volume by Type (2021-2032)
4.1.2 Global Hydrogel-based Drug Delivery Device Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Product Technology Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Hydrogel-based Drug Delivery Device Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Hydrogel-based Drug Delivery Device Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Hydrogel-based Drug Delivery Device Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Hydrogel-based Drug Delivery Device Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Hydrogel-based Drug Delivery Device Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Hydrogel-based Drug Delivery Device Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Hydrogel-based Drug Delivery Device Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Hydrogel-based Drug Delivery Device Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Hydrogel-based Drug Delivery Device Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Hydrogel-based Drug Delivery Device Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Hydrogel-based Drug Delivery Device Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Hydrogel-based Drug Delivery Device Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 AstraZeneca Plc.
11.1.1 AstraZeneca Plc. Corporation Information
11.1.2 AstraZeneca Plc. Business Overview
11.1.3 AstraZeneca Plc. Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications
11.1.4 AstraZeneca Plc. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 AstraZeneca Plc. Hydrogel-based Drug Delivery Device Sales by Product in 2025
11.1.6 AstraZeneca Plc. Hydrogel-based Drug Delivery Device Sales by Application in 2025
11.1.7 AstraZeneca Plc. Hydrogel-based Drug Delivery Device Sales by Geographic Area in 2025
11.1.8 AstraZeneca Plc. Hydrogel-based Drug Delivery Device SWOT Analysis
11.1.9 AstraZeneca Plc. Recent Developments
11.2 Columbia Laboratories Inc.
11.2.1 Columbia Laboratories Inc. Corporation Information
11.2.2 Columbia Laboratories Inc. Business Overview
11.2.3 Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications
11.2.4 Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Sales by Product in 2025
11.2.6 Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Sales by Application in 2025
11.2.7 Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Sales by Geographic Area in 2025
11.2.8 Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device SWOT Analysis
11.2.9 Columbia Laboratories Inc. Recent Developments
11.3 Mylan
11.3.1 Mylan Corporation Information
11.3.2 Mylan Business Overview
11.3.3 Mylan Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications
11.3.4 Mylan Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Mylan Hydrogel-based Drug Delivery Device Sales by Product in 2025
11.3.6 Mylan Hydrogel-based Drug Delivery Device Sales by Application in 2025
11.3.7 Mylan Hydrogel-based Drug Delivery Device Sales by Geographic Area in 2025
11.3.8 Mylan Hydrogel-based Drug Delivery Device SWOT Analysis
11.3.9 Mylan Recent Developments
11.4 Teva Pharmaceuticals USA Inc.
11.4.1 Teva Pharmaceuticals USA Inc. Corporation Information
11.4.2 Teva Pharmaceuticals USA Inc. Business Overview
11.4.3 Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications
11.4.4 Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Sales by Product in 2025
11.4.6 Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Sales by Application in 2025
11.4.7 Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Sales by Geographic Area in 2025
11.4.8 Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device SWOT Analysis
11.4.9 Teva Pharmaceuticals USA Inc. Recent Developments
11.5 Blairex Laboratories Inc.
11.5.1 Blairex Laboratories Inc. Corporation Information
11.5.2 Blairex Laboratories Inc. Business Overview
11.5.3 Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications
11.5.4 Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Sales by Product in 2025
11.5.6 Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Sales by Application in 2025
11.5.7 Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Sales by Geographic Area in 2025
11.5.8 Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device SWOT Analysis
11.5.9 Blairex Laboratories Inc. Recent Developments
11.6 ARx LLC.
11.6.1 ARx LLC. Corporation Information
11.6.2 ARx LLC. Business Overview
11.6.3 ARx LLC. Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications
11.6.4 ARx LLC. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 ARx LLC. Recent Developments
11.7 Endo International plc
11.7.1 Endo International plc Corporation Information
11.7.2 Endo International plc Business Overview
11.7.3 Endo International plc Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications
11.7.4 Endo International plc Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Endo International plc Recent Developments
11.8 BioDelivery Sciences International Inc.
11.8.1 BioDelivery Sciences International Inc. Corporation Information
11.8.2 BioDelivery Sciences International Inc. Business Overview
11.8.3 BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications
11.8.4 BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 BioDelivery Sciences International Inc. Recent Developments
11.9 Indivior PLC
11.9.1 Indivior PLC Corporation Information
11.9.2 Indivior PLC Business Overview
11.9.3 Indivior PLC Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications
11.9.4 Indivior PLC Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 Indivior PLC Recent Developments
11.10 GSK Plc
11.10.1 GSK Plc Corporation Information
11.10.2 GSK Plc Business Overview
11.10.3 GSK Plc Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications
11.10.4 GSK Plc Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 GSK Plc Recent Developments
11.11 Pfizer Inc.
11.11.1 Pfizer Inc. Corporation Information
11.11.2 Pfizer Inc. Business Overview
11.11.3 Pfizer Inc. Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications
11.11.4 Pfizer Inc. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 Pfizer Inc. Recent Developments
11.12 Aquestive Therapeutics Inc.
11.12.1 Aquestive Therapeutics Inc. Corporation Information
11.12.2 Aquestive Therapeutics Inc. Business Overview
11.12.3 Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications
11.12.4 Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 Aquestive Therapeutics Inc. Recent Developments
11.13 ZIM LABORATORIES LIMITED
11.13.1 ZIM LABORATORIES LIMITED Corporation Information
11.13.2 ZIM LABORATORIES LIMITED Business Overview
11.13.3 ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications
11.13.4 ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 ZIM LABORATORIES LIMITED Recent Developments
11.14 IntelGenx Corp.
11.14.1 IntelGenx Corp. Corporation Information
11.14.2 IntelGenx Corp. Business Overview
11.14.3 IntelGenx Corp. Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications
11.14.4 IntelGenx Corp. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 IntelGenx Corp. Recent Developments
11.15 NEXGEL
11.15.1 NEXGEL Corporation Information
11.15.2 NEXGEL Business Overview
11.15.3 NEXGEL Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications
11.15.4 NEXGEL Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 NEXGEL Recent Developments
11.16 Bliss GVS Pharma Ltd.
11.16.1 Bliss GVS Pharma Ltd. Corporation Information
11.16.2 Bliss GVS Pharma Ltd. Business Overview
11.16.3 Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications
11.16.4 Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 Bliss GVS Pharma Ltd. Recent Developments
11.17 Teika Pharmaceutical Co. Ltd.
11.17.1 Teika Pharmaceutical Co. Ltd. Corporation Information
11.17.2 Teika Pharmaceutical Co. Ltd. Business Overview
11.17.3 Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications
11.17.4 Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
11.17.5 Teika Pharmaceutical Co. Ltd. Recent Developments
11.18 Medherant Limited
11.18.1 Medherant Limited Corporation Information
11.18.2 Medherant Limited Business Overview
11.18.3 Medherant Limited Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications
11.18.4 Medherant Limited Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
11.18.5 Medherant Limited Recent Developments
11.19 Galderma
11.19.1 Galderma Corporation Information
11.19.2 Galderma Business Overview
11.19.3 Galderma Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications
11.19.4 Galderma Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
11.19.5 Galderma Recent Developments
11.20 Johnson & Johnson
11.20.1 Johnson & Johnson Corporation Information
11.20.2 Johnson & Johnson Business Overview
11.20.3 Johnson & Johnson Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications
11.20.4 Johnson & Johnson Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
11.20.5 Johnson & Johnson Recent Developments
11.21 Bausch and Lomb
11.21.1 Bausch and Lomb Corporation Information
11.21.2 Bausch and Lomb Business Overview
11.21.3 Bausch and Lomb Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications
11.21.4 Bausch and Lomb Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
11.21.5 Bausch and Lomb Recent Developments
11.22 Ferring B.V
11.22.1 Ferring B.V Corporation Information
11.22.2 Ferring B.V Business Overview
11.22.3 Ferring B.V Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications
11.22.4 Ferring B.V Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
11.22.5 Ferring B.V Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Hydrogel-based Drug Delivery Device Industry Chain
12.2 Hydrogel-based Drug Delivery Device Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Hydrogel-based Drug Delivery Device Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Hydrogel-based Drug Delivery Device Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Hydrogel-based Drug Delivery Device Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs
14 Key Findings in the Global Hydrogel-based Drug Delivery Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Hydrogel-based Drug Delivery Device Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Hydrogel-based Drug Delivery Device Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Hydrogel-based Drug Delivery Device Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Hydrogel-based Drug Delivery Device Revenue by Region (US$ Million), 2021-2026
Table 5. Global Hydrogel-based Drug Delivery Device Revenue by Region (US$ Million), 2027-2032
Table 6. Global Hydrogel-based Drug Delivery Device Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 7. Global Hydrogel-based Drug Delivery Device Sales by Region (K Units), 2021-2026
Table 8. Global Hydrogel-based Drug Delivery Device Sales by Region (K Units), 2027-2032
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 10. Global Hydrogel-based Drug Delivery Device Sales by Manufacturers (K Units), 2021-2026
Table 11. Global Hydrogel-based Drug Delivery Device Sales Share by Manufacturers (2021-2026)
Table 12. Global Hydrogel-based Drug Delivery Device Revenue by Manufacturers (US$ Million), 2021-2026
Table 13. Global Hydrogel-based Drug Delivery Device Revenue-Based Market Share by Manufacturers (2021-2026)
Table 14. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 15. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Hydrogel-based Drug Delivery Device Revenue, 2025
Table 16. Global Hydrogel-based Drug Delivery Device Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 17. Global Hydrogel-based Drug Delivery Device Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
Table 18. Key Manufacturers Hydrogel-based Drug Delivery Device Manufacturing Base and Headquarters
Table 19. Global Hydrogel-based Drug Delivery Device Market Concentration Ratio (CR5)
Table 20. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Hydrogel-based Drug Delivery Device Sales Volume by Type (K Units), 2021-2026
Table 23. Global Hydrogel-based Drug Delivery Device Sales Volume by Type (K Units), 2027-2032
Table 24. Global Hydrogel-based Drug Delivery Device Revenue by Type (US$ Million), 2021-2026
Table 25. Global Hydrogel-based Drug Delivery Device Revenue by Type (US$ Million), 2027-2032
Table 26. Technical Specifications by Key Product Type
Table 27. Global Hydrogel-based Drug Delivery Device Sales by Application (K Units), 2021-2026
Table 28. Global Hydrogel-based Drug Delivery Device Sales by Application (K Units), 2027-2032
Table 29. Hydrogel-based Drug Delivery Device High-Growth Sectors Demand CAGR (2026-2032)
Table 30. Global Hydrogel-based Drug Delivery Device Revenue by Application (US$ Million), 2021-2026
Table 31. Global Hydrogel-based Drug Delivery Device Revenue by Application (US$ Million), 2027-2032
Table 32. Top Customers by Region
Table 33. Top Customers by Application
Table 34. North America Hydrogel-based Drug Delivery Device Growth Accelerators and Market Barriers
Table 35. North America Hydrogel-based Drug Delivery Device Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 36. North America Hydrogel-based Drug Delivery Device Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 37. Europe Hydrogel-based Drug Delivery Device Growth Accelerators and Market Barriers
Table 38. Europe Hydrogel-based Drug Delivery Device Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 39. Europe Hydrogel-based Drug Delivery Device Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 40. Asia-Pacific Hydrogel-based Drug Delivery Device Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Asia-Pacific Hydrogel-based Drug Delivery Device Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 42. Asia-Pacific Hydrogel-based Drug Delivery Device Growth Accelerators and Market Barriers
Table 43. Southeast Asia Hydrogel-based Drug Delivery Device Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 44. Central and South America Hydrogel-based Drug Delivery Device Investment Opportunities and Key Challenges
Table 45. Central and South America Hydrogel-based Drug Delivery Device Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. Middle East and Africa Hydrogel-based Drug Delivery Device Investment Opportunities and Key Challenges
Table 47. Middle East and Africa Hydrogel-based Drug Delivery Device Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 48. AstraZeneca Plc. Corporation Information
Table 49. AstraZeneca Plc. Description and Major Businesses
Table 50. AstraZeneca Plc. Product Models, Descriptions and Specifications
Table 51. AstraZeneca Plc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 52. AstraZeneca Plc. Sales Value Proportion by Product in 2025
Table 53. AstraZeneca Plc. Sales Value Proportion by Application in 2025
Table 54. AstraZeneca Plc. Sales Value Proportion by Geographic Area in 2025
Table 55. AstraZeneca Plc. Hydrogel-based Drug Delivery Device SWOT Analysis
Table 56. AstraZeneca Plc. Recent Developments
Table 57. Columbia Laboratories Inc. Corporation Information
Table 58. Columbia Laboratories Inc. Description and Major Businesses
Table 59. Columbia Laboratories Inc. Product Models, Descriptions and Specifications
Table 60. Columbia Laboratories Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 61. Columbia Laboratories Inc. Sales Value Proportion by Product in 2025
Table 62. Columbia Laboratories Inc. Sales Value Proportion by Application in 2025
Table 63. Columbia Laboratories Inc. Sales Value Proportion by Geographic Area in 2025
Table 64. Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device SWOT Analysis
Table 65. Columbia Laboratories Inc. Recent Developments
Table 66. Mylan Corporation Information
Table 67. Mylan Description and Major Businesses
Table 68. Mylan Product Models, Descriptions and Specifications
Table 69. Mylan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 70. Mylan Sales Value Proportion by Product in 2025
Table 71. Mylan Sales Value Proportion by Application in 2025
Table 72. Mylan Sales Value Proportion by Geographic Area in 2025
Table 73. Mylan Hydrogel-based Drug Delivery Device SWOT Analysis
Table 74. Mylan Recent Developments
Table 75. Teva Pharmaceuticals USA Inc. Corporation Information
Table 76. Teva Pharmaceuticals USA Inc. Description and Major Businesses
Table 77. Teva Pharmaceuticals USA Inc. Product Models, Descriptions and Specifications
Table 78. Teva Pharmaceuticals USA Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 79. Teva Pharmaceuticals USA Inc. Sales Value Proportion by Product in 2025
Table 80. Teva Pharmaceuticals USA Inc. Sales Value Proportion by Application in 2025
Table 81. Teva Pharmaceuticals USA Inc. Sales Value Proportion by Geographic Area in 2025
Table 82. Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device SWOT Analysis
Table 83. Teva Pharmaceuticals USA Inc. Recent Developments
Table 84. Blairex Laboratories Inc. Corporation Information
Table 85. Blairex Laboratories Inc. Description and Major Businesses
Table 86. Blairex Laboratories Inc. Product Models, Descriptions and Specifications
Table 87. Blairex Laboratories Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Blairex Laboratories Inc. Sales Value Proportion by Product in 2025
Table 89. Blairex Laboratories Inc. Sales Value Proportion by Application in 2025
Table 90. Blairex Laboratories Inc. Sales Value Proportion by Geographic Area in 2025
Table 91. Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device SWOT Analysis
Table 92. Blairex Laboratories Inc. Recent Developments
Table 93. ARx LLC. Corporation Information
Table 94. ARx LLC. Description and Major Businesses
Table 95. ARx LLC. Product Models, Descriptions and Specifications
Table 96. ARx LLC. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. ARx LLC. Recent Developments
Table 98. Endo International plc Corporation Information
Table 99. Endo International plc Description and Major Businesses
Table 100. Endo International plc Product Models, Descriptions and Specifications
Table 101. Endo International plc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Endo International plc Recent Developments
Table 103. BioDelivery Sciences International Inc. Corporation Information
Table 104. BioDelivery Sciences International Inc. Description and Major Businesses
Table 105. BioDelivery Sciences International Inc. Product Models, Descriptions and Specifications
Table 106. BioDelivery Sciences International Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. BioDelivery Sciences International Inc. Recent Developments
Table 108. Indivior PLC Corporation Information
Table 109. Indivior PLC Description and Major Businesses
Table 110. Indivior PLC Product Models, Descriptions and Specifications
Table 111. Indivior PLC Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Indivior PLC Recent Developments
Table 113. GSK Plc Corporation Information
Table 114. GSK Plc Description and Major Businesses
Table 115. GSK Plc Product Models, Descriptions and Specifications
Table 116. GSK Plc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. GSK Plc Recent Developments
Table 118. Pfizer Inc. Corporation Information
Table 119. Pfizer Inc. Description and Major Businesses
Table 120. Pfizer Inc. Product Models, Descriptions and Specifications
Table 121. Pfizer Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Pfizer Inc. Recent Developments
Table 123. Aquestive Therapeutics Inc. Corporation Information
Table 124. Aquestive Therapeutics Inc. Description and Major Businesses
Table 125. Aquestive Therapeutics Inc. Product Models, Descriptions and Specifications
Table 126. Aquestive Therapeutics Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Aquestive Therapeutics Inc. Recent Developments
Table 128. ZIM LABORATORIES LIMITED Corporation Information
Table 129. ZIM LABORATORIES LIMITED Description and Major Businesses
Table 130. ZIM LABORATORIES LIMITED Product Models, Descriptions and Specifications
Table 131. ZIM LABORATORIES LIMITED Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. ZIM LABORATORIES LIMITED Recent Developments
Table 133. IntelGenx Corp. Corporation Information
Table 134. IntelGenx Corp. Description and Major Businesses
Table 135. IntelGenx Corp. Product Models, Descriptions and Specifications
Table 136. IntelGenx Corp. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. IntelGenx Corp. Recent Developments
Table 138. NEXGEL Corporation Information
Table 139. NEXGEL Description and Major Businesses
Table 140. NEXGEL Product Models, Descriptions and Specifications
Table 141. NEXGEL Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. NEXGEL Recent Developments
Table 143. Bliss GVS Pharma Ltd. Corporation Information
Table 144. Bliss GVS Pharma Ltd. Description and Major Businesses
Table 145. Bliss GVS Pharma Ltd. Product Models, Descriptions and Specifications
Table 146. Bliss GVS Pharma Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Bliss GVS Pharma Ltd. Recent Developments
Table 148. Teika Pharmaceutical Co. Ltd. Corporation Information
Table 149. Teika Pharmaceutical Co. Ltd. Description and Major Businesses
Table 150. Teika Pharmaceutical Co. Ltd. Product Models, Descriptions and Specifications
Table 151. Teika Pharmaceutical Co. Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Teika Pharmaceutical Co. Ltd. Recent Developments
Table 153. Medherant Limited Corporation Information
Table 154. Medherant Limited Description and Major Businesses
Table 155. Medherant Limited Product Models, Descriptions and Specifications
Table 156. Medherant Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Medherant Limited Recent Developments
Table 158. Galderma Corporation Information
Table 159. Galderma Description and Major Businesses
Table 160. Galderma Product Models, Descriptions and Specifications
Table 161. Galderma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Galderma Recent Developments
Table 163. Johnson & Johnson Corporation Information
Table 164. Johnson & Johnson Description and Major Businesses
Table 165. Johnson & Johnson Product Models, Descriptions and Specifications
Table 166. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. Johnson & Johnson Recent Developments
Table 168. Bausch and Lomb Corporation Information
Table 169. Bausch and Lomb Description and Major Businesses
Table 170. Bausch and Lomb Product Models, Descriptions and Specifications
Table 171. Bausch and Lomb Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. Bausch and Lomb Recent Developments
Table 173. Ferring B.V Corporation Information
Table 174. Ferring B.V Description and Major Businesses
Table 175. Ferring B.V Product Models, Descriptions and Specifications
Table 176. Ferring B.V Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 177. Ferring B.V Recent Developments
Table 178. Key Raw Materials Distribution
Table 179. Raw Materials Key Suppliers
Table 180. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 181. Milestones in Production Technology Evolution
Table 182. Distributors List
Table 183. Market Trends and Market Evolution
Table 184. Market Drivers and Opportunities
Table 185. Market Challenges, Risks, and Restraints
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Hydrogel-based Drug Delivery Device Product Picture
Figure 2. Global Hydrogel-based Drug Delivery Device Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Oral Product Picture
Figure 4. Buccal Product Picture
Figure 5. Rectal Product Picture
Figure 6. Vaginal Product Picture
Figure 7. Other Product Picture
Figure 8. Global Hydrogel-based Drug Delivery Device Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Other
Figure 12. Hydrogel-based Drug Delivery Device Report Years Considered
Figure 13. Global Hydrogel-based Drug Delivery Device Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Hydrogel-based Drug Delivery Device Revenue (US$ Million), 2021-2032
Figure 15. Global Hydrogel-based Drug Delivery Device Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 16. Global Hydrogel-based Drug Delivery Device Revenue-Based Market Share by Region (2021-2032)
Figure 17. Global Hydrogel-based Drug Delivery Device Sales (K Units), 2021-2032
Figure 18. Global Hydrogel-based Drug Delivery Device Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 19. Global Hydrogel-based Drug Delivery Device Sales Market Share by Region (2021-2032)
Figure 20. Top 5 and Top 10 Manufacturers Hydrogel-based Drug Delivery Device Sales Volume Market Share in 2025
Figure 21. Global Hydrogel-based Drug Delivery Device Revenue-Based Market Share Ranking (2025)
Figure 22. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 23. Oral Revenue-Based Market Share by Manufacturer in 2025
Figure 24. Buccal Revenue-Based Market Share by Manufacturer in 2025
Figure 25. Rectal Revenue-Based Market Share by Manufacturer in 2025
Figure 26. Vaginal Revenue-Based Market Share by Manufacturer in 2025
Figure 27. Other Revenue-Based Market Share by Manufacturer in 2025
Figure 28. Global Hydrogel-based Drug Delivery Device Sales Volume-Based Market Share by Type (2021-2032)
Figure 29. Global Hydrogel-based Drug Delivery Device Revenue-Based Market Share by Type (2021-2032)
Figure 30. Global Hydrogel-based Drug Delivery Device ASP by Type (US$/Unit), 2021-2032
Figure 31. Global Hydrogel-based Drug Delivery Device Revenue-Based Market Share (2021-2032)
Figure 32. Global Hydrogel-based Drug Delivery Device Sales Market Share by Application (2021-2032)
Figure 33. Global Hydrogel-based Drug Delivery Device Revenue-Based Market Share by Application (2021-2032)
Figure 34. Global Hydrogel-based Drug Delivery Device ASP by Application (US$/Unit), 2021-2032
Figure 35. North America Hydrogel-based Drug Delivery Device Sales YoY (K Units), 2021-2032
Figure 36. North America Hydrogel-based Drug Delivery Device Revenue YoY (US$ Million), 2021-2032
Figure 37. North America Top 5 Manufacturers Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) in 2025
Figure 38. North America Hydrogel-based Drug Delivery Device Sales Volume (K Units) by Application (2021-2032)
Figure 39. North America Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) by Application (2021-2032)
Figure 40. US Hydrogel-based Drug Delivery Device Revenue (US$ Million), 2021-2032
Figure 41. Canada Hydrogel-based Drug Delivery Device Revenue (US$ Million), 2021-2032
Figure 42. Mexico Hydrogel-based Drug Delivery Device Revenue (US$ Million), 2021-2032
Figure 43. Europe Hydrogel-based Drug Delivery Device Sales YoY (K Units), 2021-2032
Figure 44. Europe Hydrogel-based Drug Delivery Device Revenue YoY (US$ Million), 2021-2032
Figure 45. Europe Top 5 Manufacturers Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) in 2025
Figure 46. Europe Hydrogel-based Drug Delivery Device Sales Volume (K Units) by Application (2021-2032)
Figure 47. Europe Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) by Application (2021-2032)
Figure 48. Germany Hydrogel-based Drug Delivery Device Revenue (US$ Million), 2021-2032
Figure 49. France Hydrogel-based Drug Delivery Device Revenue (US$ Million), 2021-2032
Figure 50. U.K. Hydrogel-based Drug Delivery Device Revenue (US$ Million), 2021-2032
Figure 51. Italy Hydrogel-based Drug Delivery Device Revenue (US$ Million), 2021-2032
Figure 52. Russia Hydrogel-based Drug Delivery Device Revenue (US$ Million), 2021-2032
Figure 53. Asia-Pacific Hydrogel-based Drug Delivery Device Sales YoY (K Units), 2021-2032
Figure 54. Asia-Pacific Hydrogel-based Drug Delivery Device Revenue YoY (US$ Million), 2021-2032
Figure 55. Asia-Pacific Top 8 Manufacturers Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) in 2025
Figure 56. Asia-Pacific Hydrogel-based Drug Delivery Device Sales Volume (K Units) by Application (2021-2032)
Figure 57. Asia-Pacific Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) by Application (2021-2032)
Figure 58. Indonesia Hydrogel-based Drug Delivery Device Revenue (US$ Million), 2021-2032
Figure 59. Japan Hydrogel-based Drug Delivery Device Revenue (US$ Million), 2021-2032
Figure 60. South Korea Hydrogel-based Drug Delivery Device Revenue (US$ Million), 2021-2032
Figure 61. China Taiwan Hydrogel-based Drug Delivery Device Revenue (US$ Million), 2021-2032
Figure 62. India Hydrogel-based Drug Delivery Device Revenue (US$ Million), 2021-2032
Figure 63. Central and South America Hydrogel-based Drug Delivery Device Sales YoY (K Units), 2021-2032
Figure 64. Central and South America Hydrogel-based Drug Delivery Device Revenue YoY (US$ Million), 2021-2032
Figure 65. Central and South America Top 5 Manufacturers Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) in 2025
Figure 66. Central and South America Hydrogel-based Drug Delivery Device Sales Volume (K Units) by Application (2021-2032)
Figure 67. Central and South America Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) by Application (2021-2032)
Figure 68. Brazil Hydrogel-based Drug Delivery Device Revenue (US$ Million), 2021-2032
Figure 69. Argentina Hydrogel-based Drug Delivery Device Revenue (US$ Million), 2021-2032
Figure 70. Middle East, and Africa Hydrogel-based Drug Delivery Device Sales YoY (K Units), 2021-2032
Figure 71. Middle East and Africa Hydrogel-based Drug Delivery Device Revenue YoY (US$ Million), 2021-2032
Figure 72. Middle East and Africa Top 5 Manufacturers Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) in 2025
Figure 73. Middle East and Africa Hydrogel-based Drug Delivery Device Sales Volume (K Units) by Application (2021-2032)
Figure 74. Middle East and Africa Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) by Application (2021-2032)
Figure 75. GCC Countries Hydrogel-based Drug Delivery Device Revenue (US$ Million), 2021-2032
Figure 76. Turkey Hydrogel-based Drug Delivery Device Revenue (US$ Million), 2021-2032
Figure 77. Egypt Hydrogel-based Drug Delivery Device Revenue (US$ Million), 2021-2032
Figure 78. South Africa Hydrogel-based Drug Delivery Device Revenue (US$ Million), 2021-2032
Figure 79. Hydrogel-based Drug Delivery Device Industry Chain Mapping
Figure 80. Regional Hydrogel-based Drug Delivery Device Manufacturing Base Distribution (%)
Figure 81. Global Hydrogel-based Drug Delivery Device Production Market Share by Region (2021-2032)
Figure 82. Hydrogel-based Drug Delivery Device Production Process
Figure 83. Regional Hydrogel-based Drug Delivery Device Production Cost Structure
Figure 84. Channels of Distribution (Direct Vs Distribution)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Hydrogel-based Drug Delivery Device market?
The top companies in the global Hydrogel-based Drug Delivery Device market are AstraZeneca Plc.、Columbia Laboratories Inc.、Mylan.
Related Reports
Global Hydrogel-based Drug Delivery Device Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hydrogel-based Drug Delivery Device market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 119
USD 4250.00
(Single User License)
Hydrogel-based Drug Delivery Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hydrogel-based Drug Delivery Device was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 153
USD 3950.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Market Research Report 2026
The global Hydrogel-based Drug Delivery Device market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 140
USD 2900.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hydrogel-based Drug Delivery Device market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 197
USD 4900.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hydrogel-based Drug Delivery Device market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 117
USD 4250.00
(Single User License)
Hydrogel-based Drug Delivery Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hydrogel-based Drug Delivery Device was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 168
USD 3950.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Market Research Report 2025
The global market for Hydrogel-based Drug Delivery Device was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 112
USD 2900.00
(Single User License)
Global and United States Hydrogel-based Drug Delivery Device Market Report & Forecast 2024-2030
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
Published Date: 2024-07-07
Pages: 179
USD 4350.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Market Insights, Forecast to 2030
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
Published Date: 2024-07-07
Pages: 192
USD 4900.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Market Research Report 2024
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
Published Date: 2024-07-07
Pages: 109
USD 2900.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hydrogel-based Drug Delivery Device market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 119
USD 4250.00 (Single User License)Hydrogel-based Drug Delivery Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hydrogel-based Drug Delivery Device was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 153
USD 3950.00 (Single User License)Global Hydrogel-based Drug Delivery Device Market Research Report 2026
The global Hydrogel-based Drug Delivery Device market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 140
USD 2900.00 (Single User License)Global Hydrogel-based Drug Delivery Device Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hydrogel-based Drug Delivery Device market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 197
USD 4900.00 (Single User License)Global Hydrogel-based Drug Delivery Device Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hydrogel-based Drug Delivery Device market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 117
USD 4250.00 (Single User License)Hydrogel-based Drug Delivery Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hydrogel-based Drug Delivery Device was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 168
USD 3950.00 (Single User License)Global Hydrogel-based Drug Delivery Device Market Research Report 2025
The global market for Hydrogel-based Drug Delivery Device was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 112
USD 2900.00 (Single User License)Global and United States Hydrogel-based Drug Delivery Device Market Report & Forecast 2024-2030
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
Published: 2024-07-07
Pages: 179
USD 4350.00 (Single User License)Global Hydrogel-based Drug Delivery Device Market Insights, Forecast to 2030
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
Published: 2024-07-07
Pages: 192
USD 4900.00 (Single User License)Global Hydrogel-based Drug Delivery Device Market Research Report 2024
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
Published: 2024-07-07
Pages: 109
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now